Last Updated: November 13, 2026

Hetero Labs Ltd V Company Profile

« Back to Dashboard

What is the competitive landscape for HETERO LABS LTD V

HETERO LABS LTD V has eighty-five approved drugs.

There are two tentative approvals on HETERO LABS LTD V drugs.

Summary for Hetero Labs Ltd V

US Patents:	0
Tradenames:	80
Ingredients:	79
NDAs:	85

Drugs and US Patents for Hetero Labs Ltd V

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Hetero Labs Ltd V	OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE	amlodipine besylate; hydrochlorothiazide; olmesartan medoxomil	TABLET;ORAL	209242-003	Oct 6, 2025	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Hetero Labs Ltd V	CINACALCET HYDROCHLORIDE	cinacalcet hydrochloride	TABLET;ORAL	209403-002	Oct 7, 2020		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
Hetero Labs Ltd V	ROSUVASTATIN CALCIUM	rosuvastatin calcium	TABLET;ORAL	207616-003	Oct 31, 2016	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Hetero Labs Ltd Vi	AZACITIDINE	azacitidine	POWDER;INTRAVENOUS, SUBCUTANEOUS	215765-001	Oct 15, 2024	AP	RX	No	No		⤷ Start Trial				⤷ Start Trial
Hetero Labs Ltd V	VALSARTAN	valsartan	TABLET;ORAL	203311-003	Jan 5, 2015	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Hetero Labs Ltd V	TOLVAPTAN	tolvaptan	TABLET;ORAL	205646-001	Jul 16, 2021	AB1	RX	No	No		⤷ Start Trial				⤷ Start Trial
Hetero Labs Ltd V	VALGANCICLOVIR HYDROCHLORIDE	valganciclovir hydrochloride	FOR SOLUTION;ORAL	211475-001	Oct 4, 2022	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.